AMAG Pharmaceuticals (AMAG)
Create an Alert
20.70
+0.49 +2.42%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
AMAG Pharmaceuticals Free Cash Flow:
-9.736M for March 31, 2013AMAG Pharmaceuticals Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -9.736M |
| Dec. 31, 2012 | 16.81M |
| Sept. 30, 2012 | 3.987M |
| June 30, 2012 | -10.85M |
| March 31, 2012 | -11.15M |
| Dec. 31, 2011 | -21.75M |
| Sept. 30, 2011 | -12.45M |
| June 30, 2011 | -8.814M |
| March 31, 2011 | -21.30M |
| Dec. 31, 2010 | -13.24M |
| Sept. 30, 2010 | -20.33M |
| June 30, 2010 | 43.49M |
| March 31, 2010 | -12.66M |
| Dec. 31, 2009 | -24.76M |
| Sept. 30, 2009 | -25.17M |
| June 30, 2009 | -21.00M |
| March 31, 2009 | -22.62M |
| Dec. 31, 2008 | -23.47M |
| Sept. 30, 2008 | -18.50M |
| June 30, 2008 | -9.631M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
AMAG Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Takeda Pharmaceutical | |
| Shire | 115.80M |
| Jazz Pharmaceuticals | 63.45M |
AMAG Free Cash Flow Rankings
| Overall |
68th percentile 5306 of 16770 |
| Sector |
57th percentile 594 of 1408 in Healthcare |
| Industry |
62nd percentile 168 of 453 in Biotechnology |
AMAG Free Cash Flow Range, Past 5 Years
| Minimum | -25.17M | Sep 2009 |
| Maximum | 43.49M | Jun 2010 |
| Average | -11.16M |
